Document is current
Any future updates will be listed below
-
Authors
Vergroesen, Joëlle E.
Kaynak, Adem
Aribas, Elif
Kavousi, Maryam
van Meurs, Joyce B. J.
Klaver, Caroline C. W.
Ramdas, Wishal D. http://orcid.org/0000-0002-1780-5281
-
Funding
Funding for this research was provided by:
Stichting Glaucoomfonds
Landelijke Stichting voor Blinden en Slechtzienden
Oogfonds
Rotterdamse Stichting Blindenbelangen
Stichting Lijf en Leven
Henkes stichting
Stichting voor Ooglijders
Stichting Blindenhulp
Erasmus Medisch Centrum
Erasmus Universiteit Rotterdam
ZonMw
the Research Institute for Diseases in the Elderly
Ministerie van Onderwijs, Cultuur en Wetenschap
Ministerie van Volksgezondheid, Welzijn en Sport
Directorate-General for Research and Innovation
Municipality of Rotterdam
- License Information
-
More Information
Article History
Received: 1 December 2022
Accepted: 2 May 2023
First Online: 9 May 2023
Declarations
:
: The Rotterdam Study has been approved by the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study can be found in both the Netherlands National Trial Register (NTR; ExternalRef removed) and the WHO International Clinical Trials Registry Platform (ICTRP; ExternalRef removed) with the catalogue number NTR6831. All participants provided written informed consent according to the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
